Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYNPR antisense RNA 1 (SYNPR-AS1)
- Target
- SYNPR-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Other
01
Overview
SYNPR antisense RNA 1 (SYNPR-AS1), also known as LncFASA, is a long non-coding RNA gene located on human chromosome 3 (chr3:63421300-63645637, hg38)[5]. It is annotated as a non-protein coding antisense RNA to the SYNPR (synaptoporin) gene. The inclusion of "Ferroptosis-Associated" in some aliases suggests hypothesized or bioinformatically predicted roles in ferroptosis, though direct experimental evidence is currently lacking. Its biological activities, disease relevance, drug interactions, and utility as a biomarker remain to be determined. SYNPR-AS1 currently serves as a genomic feature of interest in gene regulation studies and ferroptosis research but is not a validated therapeutic target[5].
- Other names
- LncFASAlncRNA Ferroptosis-Associated SYNPR-AS1SYNPR antisense RNA 1 (non-protein coding)SYNPR-AS1
02
Biological functions
Regulation of gene expression (antisense regulation; general to lncRNAs)Possible involvement in ferroptosis through modulation of gene expression, inferred from its alias, but this is not directly evidenced in available literature
03
Disease associations
Other (potential association with ferroptosis and possibly involvement in diseases where ferroptosis is implicated, such as some cancers or neurodegenerative disorders, but no disease link is directly established in the provided sources)
Beyond the preview
Go deeper on SYNPR antisense RNA 1 (SYNPR-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYNPR antisense RNA 1 (SYNPR-AS1).